The test is now being evaluated for use in Sub-Saharan Africa, where researchers hope it could become the first validated rapid diagnostic test for iron deficiency.
As part of the agreement, Charles River will use technologies such as next-generation sequencing (NGS) to support chemistry, manufacturing and controls (CMC) activities associated with the vaccine programme.
GM2 gangliosidoses are a group of rare inherited disorders that cause the progressive loss of nerve cells in the brain and spinal cord.
During the first phase of the study, conducted in Osun State from 2023 to 2025, children who received PMC experienced a 22% reduction in confirmed malaria cases. Overall health facility visits for illness also fell by 19%.
Through its dedicated pavilion, BIRAC is connecting visitors, investors and industry leaders with emerging Indian innovators while highlighting how its funding, infrastructure and mentorship programmes help turn scientific research into market-ready products.
The researchers say the finding could help guide the development of more targeted treatment combinations for patients whose tumors produce the protein.
The team chemically synthesised nearly 300 of the AI-generated genomes and tested them in laboratory conditions, with sixteen of the resulting viruses proving viable.
Lilly disclosed the decision as part of its second-quarter results, removing a phase 1/2 study of LY3884961 in Gaucher disease type 1 (GD1) from its pipeline.
The Phase 1 study forms part of an expanded collaboration between Moderna and the Coalition for Epidemic Preparedness Innovations (CEPI).
The test could also help clinicians identify patients who are unlikely to benefit from immunotherapy before treatment begins, potentially allowing them to consider alternative therapies sooner.